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EDITORIALS
Development of Limb Muscle Dysfunction in Chronic Obstructive
Pulmonary Disease: Smoking, Inflammation, or Simply Disuse?
Limb muscle dysfunction in patients with chronic obstructive
pulmonary disease (COPD) represents a significant clinical problem
and is characterized by both intra- and extramuscular abnormalities
(1, 2). The predominant extramuscular change is muscle wasting,
which predicts a poor prognosis (2). The intramuscular pathology
mainly affects the quadriceps muscle. Strong evidence indicates that
patients with COPD demonstrate a shift in muscle fiber composition
from type I (oxidative, slow-twitch fibers) to type II (glycolytic, fast-
twitch fibers) when compared with healthy control subjects (3).
Likewise, the muscle fiber cross-sectional area is smaller in
individuals with COPD (4). Muscle metabolism mirrors the
structural changes, and most studies have reported a low oxidative
enzyme capacity in the quadriceps muscle of patients with COPD
(5). In contrast, although the respiratory muscles adapt to achieve a
more oxidative, fatigue-resistant profile in COPD, force generation is
subnormal and increased ventilatory work redistributes the blood
volume from locomotor to respiratory muscles (1). The functional
consequences of COPD-associated limb muscle pathophysiology
include impaired muscle strength and endurance, which leads to low
exercise performance and aggravation of dyspnea during daily
physical activities. These physiological and clinical effects are
hallmarks of COPD symptomatology.
In this issue of the Journal, Chan and colleagues (pp. 217–230)
report their findings from an animal model of cigarette smoke
(CS)-induced COPD (6). They examined the impact of CS
exposure on skeletal muscle regeneration after muscle injury (MI)
in male BALB/c mice by comparing CS-exposed (1MI) with
unexposed (1MI) mice. Two control groups of CS-exposed (2MI)
and unexposed (2MI) mice were also included. After 8 weeks of
CS exposure, the mice showed limb muscle abnormalities similar to
those observed in patients with COPD. This included muscle
atrophy and markedly reduced oxidative fiber type composition of
the hindlimb compared with unexposed mice. At this time point,
hindlimb MI was induced by injection of barium chloride, which
normally induces a robust activation of muscle satellite cells.
Muscle outcomes were evaluated over the next 3 weeks. Loss of
muscle mass and oxidative fibers was sustained throughout the
experiment in CS-exposed mice (1MI and 2MI). During the first
week after MI, muscle contractile force was also lower in CS-
exposed mice (1MI) than in unexposed mice (1MI), but gradually
recovered at 3 weeks follow-up (6). The notion that muscle force
might be restored independently of muscle fiber composition or
mass is indeed a novel concept and provides new insight into the
regenerative potential of the most commonly used countermeasure
to muscle dysfunction in COPD, namely, exercise training.
Numerous studies have explored the effects of exercise training on
muscle dysfunction in patients with COPD (4, 7–9). In an attempt
to optimize the muscular response, investigators have explored the
effects of resistance training, and although the intramuscular
structure may adapt differently to resistance training and endurance
training, the positive effects of these regimens on breathlessness and
exercise capacity are similar (8). Likewise, resistance training
provides no additional effects on muscle strength in individuals with
COPD (10). The results from Chan and colleagues indicate that the
regenerative potential is higher for muscle strength than for oxidative
fiber-type proportions or atrophy in patients with COPD. This could
explain why the intramuscular abnormalities are only partially
reversible after 8–12 weeks of pulmonary rehabilitation (4, 8).
Moreover, CS exposure seemed to reduce the activation of satellite
cells in response to MI (6), which brings into question the rationale
for using resistance training (which relies on activation of satellite
cells to regenerate damaged myofibers) as a countermeasure to
muscle dysfunction in COPD.
The etiology of limb muscle dysfunction in patients with
COPD has been debated, and one of the prevailing hypotheses
is that a local inflammatory process drives the breakdown of the
muscle. The driver of this process is low-grade inflammation in
the respiratory system, primarily caused by tobacco smoking, that
spills over into the blood and consequently into skeletal muscle.
However, investigators have not been able to confirm a highly
proinflammatory environment in the quadriceps muscle of patients
with COPD (9, 11). In CS-exposed mice, Chan and colleagues
found a universal proinflammatory response in the pulmonary,
circulatory, and muscular systems after 8 weeks of CS exposure that
may constitute the mechanistic basis for the observed muscle
adaptations (6). Studies in humans suggest that smoking impairs
the muscle protein synthesis process and increases the expression
of genes associated with impaired muscle maintenance, indicating
that smoking per se likely increases the risk of sarcopenia and that
muscle dysfunction may take place before the development of
COPD (12). Another explanation for COPD-induced muscle
dysfunction could simply be reduced physical activity. Because
physical activity was not recorded by Chan and colleagues, we can
only speculate about whether smoking induced physical inactivity
relative to controls. In patients with COPD, the intramuscular
characteristics deteriorate along with disease severity, and thus the
proportion of type I fibers in the quadriceps muscle is inversely
correlated with forced expiratory volume in 1 second (3). Hence, a
decline in lung function might reduce physical activity and thereby
contribute to the limb muscle deconditioning seen in COPD.
Finally, local muscle hypoxia might explain the maladaptation
of limb muscles in COPD. Local muscle oxygen availability is
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determined by an integrated transport system comprised of
ventilation, lung diffusion, muscle circulation, and muscle diffusion
(13), all of which are impaired in COPD. Accordingly, muscle
cells may adapt anaerobically to maintain their function in a
local hypoxic environment. This seems plausible considering
the characteristics of muscle dysfunction in COPD, including a
glycolytic fiber type dominance, higher anaerobic metabolism,
and lower oxidative enzyme activity as described above.
Direct evidence of local muscle hypoxia as a driver of muscle
dysfunction in patients with COPD is limited. However, altitude
studies in healthy subjects have shown that long-term exposure
to hypoxia results in loss of muscle mass and a reduction in
muscle fiber cross-sectional area. Likewise, muscle oxidative
capacity is reduced together with muscle contractile function
during hypoxia (14, 15). Thus, the muscle abnormalities observed
in patients with COPD and in CS-exposed mice (6) are likely
to develop in healthy individuals when they are exposed to chronic
hypoxia. n
Author disclosures are available with the text of this article at
www.atsjournals.org.
Ulrik Winning Iepsen, M.D., Ph.D.
Bente Klarlund Pedersen, M.D., DMSc.
Centre of Inflammation and Metabolism
and
Centre for Physical Activity Research
University of Copenhagen
Rigshospitalet, Denmark
ORCID ID: 0000-0002-8140-2583 (U.W.I.).
References
1. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare´ R,
et al.; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in
COPD. An official American Thoracic Society/European Respiratory
Society statement: update on limb muscle dysfunction in chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 2014;189:
e15–e62.
2. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T,
et al. Body mass, fat-free body mass, and prognosis in patients with
chronic obstructive pulmonary disease from a random population
sample: findings from the Copenhagen City Heart Study. Am J Respir
Crit Care Med 2006;173:79–83.
3. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type
shifting in the vastus lateralis of patients with COPD is associated with
disease severity: a systematic review and meta-analysis. Thorax 2007;
62:944–949.
4. Gouzi F, Pre´faut C, Abdellaoui A, Roudier E, de Rigal P, Molinari N, et al.
Blunted muscle angiogenic training-response in COPD patients
versus sedentary controls. Eur Respir J 2013;41:806–814.
5. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Be´langer M, et al.
Oxidative enzyme activities of the vastus lateralis muscle and the
functional status in patients with COPD. Thorax 2000;55:848–853.
6. Chan SMH, Cerni C, Passey S, Seow HJ, Bernardo I, van der Poel C,
et al. Cigarette smoking exacerbates skeletal muscle injury without
compromising its regenerative capacity. Am J Respir Cell Mol Biol
2020;62:217–230.
7. Spruit MA, Gosselink R, Troosters T, De Paepe K, Decramer M.
Resistance versus endurance training in patients with COPD and
peripheral muscle weakness. Eur Respir J 2002;19:1072–1078.
8. Iepsen UW, Munch GDW, Rugbjerg M, Rinnov AR, Zacho M, Mortensen
SP. Effect of endurance versus resistance training on quadriceps
muscle dysfunction in COPD: a pilot study. Int J Chron Obstruct
Pulmon Dis 2016;11:2659–2669.
9. Ryrsø CK, Thaning P, Siebenmann C, Lundby C, Lange P, Pedersen BK,
et al. Effect of endurance versus resistance training on local muscle
and systemic inflammation and oxidative stress in COPD. Scand J
Med Sci Sports 2018;28:2339–2348.
10. Iepsen UW, Jørgensen KJ, Ringbaek T, Hansen H, Skrubbeltrang C,
Lange P. A systematic review of resistance training versus endurance
training in COPD. J Cardiopulm Rehabil Prev 2015;35:163–172.
11. Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB,
et al.; ENIGMA in COPD project. Cytokine profile in quadriceps
muscles of patients with severe COPD. Thorax 2008;63:100–107.
12. Petersen AM, Magkos F, Atherton P, Selby A, Smith K, Rennie MJ,
et al. Smoking impairs muscle protein synthesis and increases
the expression of myostatin and MAFbx in muscle. Am J Physiol
Endocrinol Metab 2007;293:E843–E848.
13. Wagner PD. The physiological basis of pulmonary gas exchange:
implications for clinical interpretation of arterial blood gases. Eur
Respir J 2015;45:227–243.
14. MacDougall JD, Green HJ, Sutton JR, Coates G, Cymerman A, Young
P, et al. Operation Everest II: structural adaptations in skeletal
muscle in response to extreme simulated altitude. Acta Physiol
Scand 1991;142:421–427.
15. Green HJ, Sutton JR, Cymerman A, Young PM, Houston CS. Operation
Everest II: adaptations in human skeletal muscle. J Appl Physiol
(1985) 1989;66:2454–2461.
EDITORIALS
Editorials 135
 
